Tyrosine kinase inhibitors

Details for Australian Patent Application No. 2006306517 (hide)

Owner Merck & Co., Inc.

Inventors Northrup, Alan B.; Lim, Jongwon; Dinsmore, Christopher J.

Agent Spruson & Ferguson

Pub. Number AU-A-2006306517

PCT Pub. Number WO2007/050401

Priority 60/729,071 21.10.05 US

Filing date 18 October 2006

Wipo publication date 3 May 2007

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 243/10 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/050401 Priority application(s): WO2007/050401

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306521-The induction of indoleamine 2,3-dioxygenase in dendritic cells by TLR ligands and uses thereof

2006306512-Test strip container with integrated meter having strip coding capability